Regulatory T cells thrive in ammonia-rich tumors

Area of Science:

• Immunology
• Cancer Biology
• Metabolic Pathways

Background:

• Regulatory T (Treg) cells are crucial for immune homeostasis but can also suppress anti-tumor immunity.
• Tumor microenvironments often exhibit altered metabolic states, including high ammonia levels.
• Resistance to immune checkpoint inhibitors like anti-PD-1 therapy remains a significant clinical challenge.

Purpose of the Study:

• To investigate the metabolic mechanisms by which Treg cells promote immunosuppression in the tumor microenvironment.
• To explore the role of tumor-derived ammonia in Treg cell function and therapeutic resistance.
• To identify potential metabolic targets for overcoming resistance to anti-PD-1 therapy.

Main Methods:

• Analysis of Treg cell metabolism in tumor-bearing models.
• Measurement of ammonia levels and metabolic flux.
• Investigation of the urea cycle and spermine synthesis pathways in Treg cells.
• Assessment of PPARγ-dependent oxidative phosphorylation.
• Evaluation of tumor glutamine metabolism inhibition.
• Testing the efficacy of combined metabolic inhibition and anti-PD-1 therapy.

Main Results:

• Treg cells metabolize tumor-derived ammonia through the urea cycle and spermine synthesis.
• This metabolic process promotes immunosuppression via PPARγ-dependent oxidative phosphorylation.
• Inhibition of tumor glutamine metabolism effectively reduces ammonia levels.
• Reducing ammonia levels overcomes Treg cell-mediated resistance to anti-PD-1 therapy.

Conclusions:

• Tumor-derived ammonia metabolism by Treg cells is a key mechanism of immunosuppression.
• Targeting tumor glutamine metabolism represents a viable strategy to enhance anti-PD-1 immunotherapy.
• Metabolic interventions hold promise for overcoming treatment resistance in cancer.